Author Shawn Peters blends clarity and rigor to make data structures and algorithms accessible to all learners. COLORADO, CO, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Vibrant Publishers ...

A new graphic novel both celebrates and demystifies the colorful frontier icon, while also correcting some of her taller tales. By Michael Wallis Lola Lafon’s book “When You Listen to This Song” is a ...

Your ultimate L.A. Bookshelf is here — a guide to the 110 essential L.A. books, plus essays, supporting quotes and a ranked list of the best of the best. In advance of this year’s Los Angeles Times ...

Imani Perry follows Sara Birmingham to Random House in a two-book deal, Viking takes Isle McElroy’s third novel, and more.

FOX News Books features titles from FOX News personalities, including FOX & Friends First co-host Carley Shimkus, FOX News Sunday anchor Shannon Bream, The Faulkner Focus and Outnumbered host Harris ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

From terrifying paranormal tales to nail-biting thrillers and everything in between, these are the best Stephen King books in every genre that you'll devour Our editors and experts handpick every ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

November 25, 2025 The Book Show | Chloe Dalton - Raising Hare When Chloe Dalton, a city-dwelling professional with a high-pressure job, finds a newly born hare - endangered, alone and no bigger than ...

One of my favorite holiday traditions is getting comfy, grabbing my favorite holiday drink and treat, and settling down with a stack of the best Christmas novels, new and old. Is there anything cozier ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...